These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16982690)

  • 21. Selective contribution of Tyk2 to cell activation by lipopolysaccharide.
    Schneider A; Reichart U; Gerner W; Kolbe T; Saalmüller A; Müller M
    FEBS Lett; 2008 Oct; 582(25-26):3681-6. PubMed ID: 18845149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.
    Fuchs S; Kaiser-Labusch P; Bank J; Ammann S; Kolb-Kokocinski A; Edelbusch C; Omran H; Ehl S
    Eur J Immunol; 2016 Nov; 46(11):2639-2649. PubMed ID: 27615517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2).
    Min X; Ungureanu D; Maxwell S; Hammarén H; Thibault S; Hillert EK; Ayres M; Greenfield B; Eksterowicz J; Gabel C; Walker N; Silvennoinen O; Wang Z
    J Biol Chem; 2015 Nov; 290(45):27261-27270. PubMed ID: 26359499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells.
    Marroqui L; Dos Santos RS; Fløyel T; Grieco FA; Santin I; Op de Beeck A; Marselli L; Marchetti P; Pociot F; Eizirik DL
    Diabetes; 2015 Nov; 64(11):3808-17. PubMed ID: 26239055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of Leishmania major in the absence of Tyk2 kinase.
    Schleicher U; Mattner J; Blos M; Schindler H; Röllinghoff M; Karaghiosoff M; Müller M; Werner-Felmayer G; Bogdan C
    Eur J Immunol; 2004 Feb; 34(2):519-29. PubMed ID: 14768057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of tyrosine kinase 2 (Tyk2) on the proteome of murine macrophages and their response to lipopolysaccharide (LPS).
    Radwan M; Miller I; Grunert T; Marchetti-Deschmann M; Vogl C; O'Donoghue N; Dunn MJ; Kolbe T; Allmaier G; Gemeiner M; Müller M; Strobl B
    Proteomics; 2008 Sep; 8(17):3469-85. PubMed ID: 18683816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
    Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
    Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.
    Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H
    Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.
    Ishizaki M; Muromoto R; Akimoto T; Ohshiro Y; Takahashi M; Sekine Y; Maeda H; Shimoda K; Oritani K; Matsuda T
    Int Immunol; 2011 Sep; 23(9):575-82. PubMed ID: 21765170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction.
    Velazquez L; Mogensen KE; Barbieri G; Fellous M; Uzé G; Pellegrini S
    J Biol Chem; 1995 Feb; 270(7):3327-34. PubMed ID: 7531704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.
    Barbieri G; Velazquez L; Scrobogna M; Fellous M; Pellegrini S
    Eur J Biochem; 1994 Jul; 223(2):427-35. PubMed ID: 8055912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.
    Bosmann M; Strobl B; Kichler N; Rigler D; Grailer JJ; Pache F; Murray PJ; Müller M; Ward PA
    J Leukoc Biol; 2014 Jul; 96(1):123-31. PubMed ID: 24604832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyk2 and Stat3 regulate brown adipose tissue differentiation and obesity.
    Derecka M; Gornicka A; Koralov SB; Szczepanek K; Morgan M; Raje V; Sisler J; Zhang Q; Otero D; Cichy J; Rajewsky K; Shimoda K; Poli V; Strobl B; Pellegrini S; Harris TE; Seale P; Russell AP; McAinch AJ; O'Brien PE; Keller SR; Croniger CM; Kordula T; Larner AC
    Cell Metab; 2012 Dec; 16(6):814-24. PubMed ID: 23217260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes.
    Vogl C; Flatt T; Fuhrmann B; Hofmann E; Wallner B; Stiefvater R; Kovarik P; Strobl B; Müller M
    BMC Genomics; 2010 Mar; 11():199. PubMed ID: 20338026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
    Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
    Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity.
    Strobl B; Stoiber D; Sexl V; Mueller M
    Front Biosci (Landmark Ed); 2011 Jun; 16(9):3214-32. PubMed ID: 21622231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17-Regulated mRNA Stabilization.
    Muromoto R; Tawa K; Ohgakiuchi Y; Sato A; Saino Y; Hirashima K; Minoguchi H; Kitai Y; Kashiwakura JI; Shimoda K; Oritani K; Matsuda T
    Immunohorizons; 2019 May; 3(5):172-185. PubMed ID: 31356171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2.
    Rani MR; Gauzzi C; Pellegrini S; Fish EN; Wei T; Ransohoff RM
    J Biol Chem; 1999 Jan; 274(4):1891-7. PubMed ID: 9890942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation.
    Shimoda K; Kamesaki K; Numata A; Aoki K; Matsuda T; Oritani K; Tamiya S; Kato K; Takase K; Imamura R; Yamamoto T; Miyamoto T; Nagafuji K; Gondo H; Nagafuchi S; Nakayama K; Harada M
    J Immunol; 2002 Nov; 169(9):4707-11. PubMed ID: 12391177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.